Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Overall Survival of CDK4/6-Inhibitors-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisJ. Natl. Cancer Inst 2020 May 14;[EPub Ahead of Print], F Schettini, F Giudici, M Giuliano, M Cristofanilli, G Arpino, L Del Mastro, F Puglisi, S De Placido, I Paris, P De Placido, S Venturini, M De Laurentis, P Conte, D Juric, A Llombart-Cussac, L Pusztai, A Prat, G Jerusalem, A Di Leo, D Generali
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.